Información del artículo
El Texto completo está disponible en PDF
References
[1.]
Y.S. Chatzizisis, G. Misirli, A.I. Hatzitolios, G.D. Giannoglou.
The syndrome of rhabdomyolysis: complications and treatment.
Eur J Intern Med, 19 (2008), pp. 568-574
[2.]
G. Melli, V. Chaudhry, D.R. Cornblath.
Rhabdomyolysis: an evaluation of 475 hospitalized patients.
Medicine (Baltimore), 84 (2005), pp. 377-385
[3.]
Y. Kaymac.
Creatine phosphokinase values during isotretinoin treatment for acne.
Int J Dermatol, 47 (2008), pp. 398-401
[4.]
M. Landau, R. Mesterman, J. Ophir, B. Mevorah, J. Alcalay, A. Harel, et al.
Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin.
Acta Derm Venereol, 81 (2001), pp. 350-352
[5.]
E. Guttman-Yassky, T. Hayek, L. Muchnik, R. Bergman.
Acute rhabdomyolysis and myoglobinuria associated with isotretinoin treatment.
Int J Dermatol, 42 (2003), pp. 499-500
[6.]
E.I. McBurney, D.A. Rosen.
Elevated creatine phosphokinase with isotretinoin.
J Am Acad Dermatol, 10 (1984), pp. 528-529
[7.]
E. Hodak, N. Gadoth, M. David, M. Sandbank.
Muscle damage induced by isotretinoin.
Br Med J (Clin Res Ed), 293 (1986), pp. 425-426
[8.]
M.A. Trauner, B.S. Ruben.
Isotretinoin induced rhabdomyolysis? A case report.
Dermatol Online J, 5 (1999), pp. 2
[9.]
V. Mougios.
Reference intervals for serum creatine kinase in athletes.
Br J Sports Med, 41 (2007), pp. 674-678
[10.]
E. Chroni, A. Monastirli.
Tsambaos. Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.
Drug Saf, 33 (2010), pp. 25-34
Copyright © 2011. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
